Logo image
Intermittent lysis on a single paper-based device to extract exosomal nucleic acid biomarkers from biological samples for downstream analysis
期刊文章

Intermittent lysis on a single paper-based device to extract exosomal nucleic acid biomarkers from biological samples for downstream analysis

V.-T. Vu, C.-A. Vu, C.-J. Huang, C.-M. Cheng, S.-C. Pan 和 W.-Y. Chen
Microchimica Acta, 卷.191(8)
2024
Web of Science ID: WOS:001282753100002

摘要

Chronic wound Exosomal biomarker Exosomal nucleic acid extraction Human plasma Intermittent lysis Paper-based device Silica nanoparticles Biomarkers, Tumor Exosomes Humans MicroRNAs Paper Point-of-Care Testing Tetraspanin 30 Biomarkers Biomolecules Diseases Nucleic acids Sols CD63 antigen CD63 protein, human microRNA MIRN21 microRNA, human tumor marker Biological samples Chronic wounds Down-stream Exosomal biomarker Exosomal nucleic acid extraction Human plasmas Intermittent lyse Nucleic acids extractions Paper based devices Silica nanoparticles blood chemistry exosome human metabolism paper point of care testing Silica nanoparticles
As the role of exosomes in physiological and pathological processes has been properly perceived, harvesting them and their internal components is critical for subsequent applications. This study is a debut of intermittent lysis, which has been integrated into a simple and easy-to-operate procedure on a single paper-based device to extract exosomal nucleic acid biomarkers for downstream analysis. Exosomes from biological samples were captured by anti-CD63-modified papers before being intermittently lysed by high-temperature, short-time treatment with double-distilled water to release their internal components. Exosomal nucleic acids were finally adsorbed by sol–gel silica for downstream analysis. Empirical trials not only revealed that sporadically dropping 95 °C ddH2O onto the anti-CD63-modified papers every 5 min for 6 times optimized the exosomal nucleic acids extracted by the anti-CD63 paper but also verified that the whole deployed procedure is applicable for point-of-care testing (POCT) in low-resource areas and for both in vitro (culture media) and in vivo (plasma and chronic lesion) samples. Importantly, downstream analysis of exosomal miR-21 extracted by the paper-based procedure integrated with this novel technique discovered that the content of exosomal miR-21 in chronic lesions related to their stages and the levels of exosomal carcinoembryonic antigen originated from colorectal cancer cells correlated to their exosomal miR-21. Graphical Abstract: (Figure presented.). © The Author(s), under exclusive licence to Springer-Verlag GmbH Austria, part of Springer Nature 2024.

檔案與連結 (1)

url
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85200268094&doi=10.1007%2fs00604-024-06566-z&partnerID=40&md5=9a47cb7680f72184c1a5b3a2df101b2f檢視

相關連結

InCites亮點

本研究成果之相關指標(擷取自 InCites Benchmarking & Analytics)

合作類型
機構合作
引用書目主題
1 Clinical & Life Sciences
1.196 Micro & Long Noncoding RNA
1.196.1475 Extracellular Vesicles
Web Of Science研究領域
Chemistry, Analytical
ESI研究領域
Chemistry

聯合國永續發展目標(SDGs)

此研究成果有助於達成以下目標:

#3 Good Health and Well-Being

來源:來自InCites的SDGs

詳細資料

Logo image